Skip to main content
. 2019 Nov 10;20(22):5621. doi: 10.3390/ijms20225621

Figure 2.

Figure 2

RNA editing and clinico-pathological features. Incidence of RNA editing-high tumors are plotted for different features of breast cancer. Pathological (Path.) stage and T and N TNM values are as per the American Joint Committee on Cancer staging system. Indicators of breast cancer subtypes are as follows: L, luminal type; LH, luminal-HER2; H, HER2; T, triple negative. For MKI67 gene expression, the median gene expression value was used to identify low and high groups. p-values were determined with Fisher′s exact test. ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.